Abstract:Mutations in E3 ubiquitin ligase Parkin and Ser/Thr protein kinase Pink1 cause autosomally inherited parkinsonism. Genetic studies have shown that Pink1 and Parkin act in the same pathway that regulates mitochondria dynamics, motility, and quality control. Activation of this pathway can be triggered by a variety of cellular stressor signals that cause mitochondrial damage. Here, we present evidence that PINK1‐Parkin has both cytoprotective and pro‐apoptotic functions. PINK1‐Parkin operates as a molecular switch to dictate cell fate decisions in response to different cellular stressors. Cells exposed to severe and irreparable mitochondrial damage agents such as valinomycin can undergo PINK1‐Parkin‐dependent apoptosis. The proapoptotic response elicited by valinomycin is associated with the degradation of Mcl‐1. PINK1 directly phosphorylates Parkin at Ser65 of its Ubl domain and triggers activation of its E3 ligase activity through an autocatalytic mechanism which amplifies its E3 ligase activity towards Mcl‐1. Autocatalytic activation of Parkin bolsters it accumulation on mitochondria and apoptotic response to valinomycin. Our results suggest that PINK1‐Parkin constitutes a damage‐gated molecular switch that governs cellular context‐specific cell fate decisions in response to variable stress stimuli. We developed an analog sensitive PINK1 allele and demonstrated that PINK1 is required for triggering Parkin translocation to mitochondria, but is dispensable for sustaining Parkin accumulation and consequent mitophagy. Support or Funding Information This work was supported by grants from a Butcher Award from the University of Colorado and National Institutes of Health CA107098 and GM113141 to Xuedong Liu. The ImageXpress MicroXL was supported by a NCRR grant S10 RR026680 from NIH.

Mitochondrial-Dependent and Independent Functions of PINK1

The Regulatory Role of PINK1 in The Inflammation and Immune Response

PINK1: the Guard of Mitochondria.

PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models

PINK1-PRKN mediated mitophagy: differences between <i>in vitro</i> and <i>in vivo</i> models

PINK1-G411S mutant increases kinase stability and enhances mitochondrial-linked functions

[PINK1 and the Related Diseases].

PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin

PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling

The Pink-Parkin Circuit in Mitochondrial Quality Control

Analysis of Neuronal Phosphoproteome Reveals PINK1 Regulation of BAD Function and Cell Death.

The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria

Pink1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy

Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons

PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease

Loss of PINK1 causes age-dependent mitochondrial trafficking deficits in nigrostriatal dopaminergic neurons through aberrant activation of p38 MAPK

Pink1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit And Alpha-Synuclein Aggregation In Cell Culture Models Of Parkinson'S Disease

The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease

The Parkinson's disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1.

The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease